Literature DB >> 25256885

Changes in quality of life following group CBT for anxiety and depression in a psychiatric outpatient clinic.

Tian Po Oei1, Niamh May McAlinden2.   

Abstract

The present study examined the relationship between quality of life and symptom change following group CBT treatment for anxiety or depression in a psychiatric hospital outpatient setting. One hundred seventy seven outpatients undergoing eight sessions of group CBT for anxiety (n=124) or mood disorders (n=53) participated. The Beck Anxiety Inventory (BAI), Zung Self-Rating Depression Scale (Zung-SRDS), Quality of Life Inventory (QOLI), and Satisfaction with Life Scale (SWLS) were administered at baseline and post-treatment. Additionally, the QOLI and SWLS scores of those who achieved reliable improvement or clinically significant symptom change were compared to those who experienced no reliable symptom improvement. There were significant changes across the QOLI, SWLS, BAI and Zung-SRDS outcome measures between baseline and post-treatment, with moderate to very large effect sizes observed. Patients with reliable or clinically significant change in their symptoms experienced significant increases in QOLI and SWLS scores when compared to those whose symptoms did not change reliably. Overall, in a psychiatric hospital outpatient setting, group CBT appeared to be successful in increasing quality of life and satisfaction with life in addition to reducing anxiety and depression symptoms.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety disorders; Cognitive therapy; Group psychotherapy; Mood disorders; Treatment outcome

Mesh:

Year:  2014        PMID: 25256885     DOI: 10.1016/j.psychres.2014.08.036

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

Review 1.  Effect of treatments for depression on quality of life: a meta-analysis.

Authors:  Stefan G Hofmann; Joshua Curtiss; Joseph K Carpenter; Shelley Kind
Journal:  Cogn Behav Ther       Date:  2017-04-25

2.  Upregulating the positive affect system in anxiety and depression: Outcomes of a positive activity intervention.

Authors:  Charles T Taylor; Sonja Lyubomirsky; Murray B Stein
Journal:  Depress Anxiety       Date:  2017-01-06       Impact factor: 6.505

3.  A pragmatic randomized controlled trial of a group self-management support program versus treatment-as-usual for anxiety disorders: study protocol.

Authors:  Pasquale Roberge; Janie Houle; Jean-Rémy Provost; Simon Coulombe; Annie Beaudin; Peter Bower; Félix Camirand Lemyre; Martin Drapeau; Marc-Simon Drouin; Catherine Hudon; Martin D Provencher; Helen-Maria Vasiliadis
Journal:  BMC Psychiatry       Date:  2022-02-21       Impact factor: 3.630

4.  "Despite the Differences, We Were All the Same". Group Cohesion in Diagnosis-Specific and Transdiagnostic CBT Groups for Anxiety and Depression: A Qualitative Study.

Authors:  Anne Bryde Christensen; Signe Wahrén; Nina Reinholt; Stig Poulsen; Morten Hvenegaard; Erik Simonsen; Sidse Arnfred
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

5.  A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol.

Authors:  Pasquale Roberge; Martin D Provencher; Patrick Gosselin; Helen-Maria Vasiliadis; Isabelle Gaboury; Annie Benoit; Martin M Antony; Nils Chaillet; Janie Houle; Catherine Hudon; Peter J Norton
Journal:  BMC Psychiatry       Date:  2018-10-03       Impact factor: 3.630

6.  Effects of cognitive behavioral therapy for depression on improving insomnia and quality of life in Chinese women with breast cancer: results of a randomized, controlled, multicenter trial.

Authors:  Huihua Qiu; Wenwei Ren; Yanjie Yang; Xiongzhao Zhu; Guangyun Mao; Shanping Mao; Yan Lin; Shanshan Shen; Changjin Li; Hongying Shi; Suo Jiang; Jingjing He; Ke Zhao; Ye Fu; Xiaoqu Hu; Yingying Gu; Kai Wang; Xiuchan Guo; Jincai He
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-10       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.